Danaher completes $5.7 billion Abcam acquisition
By 
Anthony King2023-12-08T11:11:00
Deal proceeded despite significant opposition from founder and ex-chief Jonathan Milner
US group Danaher has completed its takeover of Abcam, a UK firm specialising in antibodies and life science consumables, for $5.7 billion (£4.5 billion) in cash.
The sale had faced opposition from Abcam founder Jonathan Milner, who accused the Abcam board of poor performance during the summer. Milner, who owned around 6% of the company, issued an open letter to shareholders in September in response to the announcement of the deal in August.